NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51672-4045
Requested NDC: 51672-4045-01
Package NDCs from labels: 51672-4045-1, 51672-4045-3, 51672-4045-01
Manufacturer: Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
Effective date: 2026-07-14
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Enalapril Maleate and Hydrochlorothiazide Tablets, USP	Sun Pharmaceutical Industries, Inc. \| Taro Pharmaceutical Industries, Ltd.	2026-07-14	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51672-4045-1	Enalapril Maleate and Hydrochlorothiazide	100 in 1 BOTTLE	TABLET	100		12
51672-4045-3	Enalapril Maleate and Hydrochlorothiazide	1000 in 1 BOTTLE	TABLET	1000		12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51672-4045	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	12	Current NDC, Legacy NDC, 2 package rows	20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51672-4045-1	EA - Each	51672-4045	65069710-3c5b-4339-ba87-09ceb26cf720	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Enalapril Maleate	ACTIVE INGREDIENT	9O25354EPJ	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
Hydrochlorothiazide	ACTIVE INGREDIENT	0J48LPH2TH	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
Enalaprilat Anhydrous	ACTIVE MOIETY	Q508Q118JM	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
Hydrochlorothiazide	ACTIVE MOIETY	0J48LPH2TH	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
ferric oxide yellow	INACTIVE INGREDIENT	EX438O2MRT	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
sodium bicarbonate	INACTIVE INGREDIENT	8MDF5V39QO	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5
water	INACTIVE INGREDIENT	059QF0KO0R	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]	5

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 49 of 52 · 1,028 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Bryant Ranch Prepack	4c3403a6-da6a-4f37-bc7e-9fe0aa284305	2021-12-07	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Lisinopril and Hydrochlorothiazide	LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS	Cipla USA Inc.	40e6b627-63dc-4d52-aaa8-750663ad86c2	2021-11-05	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Aphena Pharma Solutions - Tennessee, LLC	b129e54a-a6d8-42c0-baac-e8db2487369b	2021-11-05	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
triamterene and hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Aphena Pharma Solutions - Tennessee, LLC	236dead0-16d5-4383-860f-30743730a088	2021-10-28	Boxed warning, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Sterile Water	STERILE WATER	B. Braun Medical Inc.	d99f9133-e4d0-4dee-b611-dbc3f918b547	2021-08-09	Warnings, Adverse reactions	Exact identifier unii: 059QF0KO0R
Sterile Water	WATER	B. Braun Medical Inc.	8924e52e-8622-4ed6-a061-1908183e0a18	2021-08-06	Warnings, Adverse reactions	Exact identifier unii: 059QF0KO0R
Eyewash	EYEWASH	Global Equipment Company	c4f78121-4668-2e0c-e053-2995a90ab6c6	2021-06-17	Warnings	Exact identifier unii: 059QF0KO0R
candesartan cilexetil and hydrochlorothiazide	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	Solco Healthcare LLC	543b9806-ccfa-4144-a2a2-d0e35eaceeee	2021-05-21	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
8.4% SODIUM BICARBONATE	8.4% SODIUM BICARBONATE	HF Acquisition Co. LLC, DBA HealthFirst	74d8bb7a-9e7a-105f-e053-2a91aa0aec92	2021-05-03	Warnings, Adverse reactions	Exact identifier unii: 8MDF5V39QO
SODIUM BICARBONATE	SODIUM BICARBONATE	Medical Purchasing Solutions, LLC	bfc9c321-665c-ca97-e053-2995a90a7954	2021-04-12	Warnings, Adverse reactions	Exact identifier unii: 8MDF5V39QO
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Aphena Pharma Solutions - Tennessee, LLC	f0b993f2-9771-42e3-b10e-09719189e2bd	2021-01-19	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Sterile Water	WATER	Asclemed USA, Inc.	45c38269-883c-4198-a9d5-03810a4420ec	2021-01-14	Warnings, Adverse reactions	Exact identifier unii: 059QF0KO0R
Triamterene and Hydrochlorothiazide	TRIAMTERENE AND HYDROCHLOROTHIAZIDE	Proficient Rx LP	f11598d2-87ee-4292-8631-c29c54f4dfa9	2021-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Proficient Rx LP	6be05675-c4b4-4e1e-9047-044a7fc7cef6	2021-01-01	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Irbesartan and Hydrochlorothiazide	IRBESARTAN AND HYDROCHLOROTHIAZIDE	Proficient Rx LP	97b09783-7bba-4f7a-b1b3-86ccf12c7ecc	2021-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Losartan Potassium and Hydrochlorothiazide	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	Proficient Rx LP	a6e7d8a7-f969-4a21-ac28-93c77ed1fa63	2021-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Valsartan and Hydrochlorothiazide	VALSARTAN AND HYDROCHLOROTHIAZIDE	Proficient Rx LP	75b3f944-b4fc-40a5-a4e2-aec2fbab64b8	2021-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	Teva Pharmaceuticals USA, Inc.	5c128ef2-60a6-40f3-b37f-ee139fe27987	2021-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Hydrochlorothiazide	HYDROCHLOROTHIAZIDE	Proficient Rx LP	78c04f59-65c3-4a16-83a6-ed4a409afce5	2021-01-01	Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH
Losartan Potassium and Hydrochlorothiazide	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	Proficient Rx LP	6dd115b5-9268-4b66-bae8-0aa2605ebbd3	2021-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 0J48LPH2TH

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.